In the case of SARS-CoV-2, it has been reported that IgA antibodies that bind to the virus are rapidly produced, even before IgG antibodies, and can be detected in the serum and saliva of COVID-19 patients up to around 40 days post onset of symptoms as well8–11. Here, CD79A is linked to COVID-19.